City

Hong Kong (1)

San Antonio (1)

Condition

Impaired Fasting Glucose (IFG) (2)

Impaired Glucose Tolerance (IGT) (2)

Diabetes (1)

Diabetes Mellitus, Type 2 (1)

Glucose Intolerance (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

Sponsor

Chinese University of Hong Kong (1)

The University of Texas Health Science Center at San Antonio (1)

Collaborator

American Diabetes Association (1)

AstraZeneca (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Intervention

dapagliflozin (1)

metformin (1)

observational: no treatment involved (1)

pioglitazone (1)

saxagliptin (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

impaired fasting glucose (ifg)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting

Diabetes Mellitus, Type 2
+2 more

Dapagliflozin
+3 more

San Antonio, Texas

The University of Texas Health Science Center at San Antonio

Aug 29, 2022

A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese

Unknown status

Diabetes
+3 more

observational: no treatment involved

Hong Kong, China

Gary Ko

Aug 21, 2015